Skip to main content

Table 5 Multivariate analysis of the survival of IPSS-R lower-risk subjects with respect to dysplastic mono-nucleated megakaryocytes

From: A systematic classification of megakaryocytic dysplasia and its impact on prognosis for patients with myelodysplastic syndromes

 

HR

95 % CI

P value

Age (year)

  

0.03

 ≥60

1.808

1.058–3.089

 

 <60*

1.0

  

Gender

  

0.161

 IPSS-R

  

0.018

 Very-low

0

0–1.07E266

 

 Low

0.463

0.272–0.789

 

 Intermediate*

1.0

  

Mono-nucleated (%)

  

<0.01

 ≥30

2.672

1.410–5.064

 

 <30*

1.0

  
  1. * The reference
Back to article page

Experimental Hematology & Oncology

ISSN: 2162-3619

Contact us